Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542

Japan

Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

Evaluate Japan Drug Forecasts to 2022

Conduct external benchmarking & market analysis with the first consensus forecasts for Japan.

Our industry-leading consensus forecasts, combined with historical sales and sales by indication for the Japanese market will help you make business critical decisions faster.

Evaluate Japan Drug Forecasts cover over 1,000 marketed and R&D products which make up over 80% of the total Japanese market value in 2016.


Japan Drug Forecasts
Japan Drug Forecasts

EvaluatePharma Japan Drug Forecasts offer a single solution for business development and licensing, commercial and corporate strategy, consultants and investment banks:


Product Valuation
Create product and company portfolio valuations for Japan market with standardised consensus forecasts to 2022

Competitive Analysis
Benchmark product performance and map uptake trends and key drivers for Japan market

Market Sizing
Model the future dynamics of the Japanese market to 2022 and compare worldwide, USA and EU consensus forecasts

Sales by Indication
Model product sales at indication level and identify the key growth drivers

Horizon Scanning
Map pipeline assets likely to launch by 2022 and measure impact to understand future asset value

Evaluate Japan Drug Forecasts are available as an add on module to EvaluatePharma.

Evaluate Japan Drug
Forecasts to 2022 Brochure

Japan Market Focus -
Total Sales

Japan Market Focus -
Top 5 PD-L1 Products

Japan Drug Forecasts Japan Drug Forecasts Japan Drug Forecasts
ENGLISH | 日本語 ENGLISH | 日本語 ENGLISH



Contact us today for more info